{"disease":{"id":"ovarian-response","name":"ovarian response"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03522246","title":"A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1097,"lead_sponsor_name":"pharmaand GmbH","has_results":true},{"nct_id":"NCT01844986","title":"Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":450,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT01874353","title":"Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":327,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT04717752","title":"A Randomized Controlled Study of Different Trigger Modes of Antagonist Regimen in Patients With Low Ovarian Reserve","phase":"NA","overall_status":"UNKNOWN","enrollment_count":310,"lead_sponsor_name":"Nanjing University","has_results":false},{"nct_id":"NCT06645379","title":"Application of Platelet-rich Plasma (PRP) in Reproductive Medicine","phase":"NA","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"The Fourth Affiliated Hospital of Zhejiang University School of Medicine","has_results":false},{"nct_id":"NCT03388099","title":"Impact of Gonadotrophin REceptor Polimorphisms on the Relationship Between Serum AMH and Ovarian Response","phase":"","overall_status":"COMPLETED","enrollment_count":296,"lead_sponsor_name":"Instituto Valenciano de Infertilidad, IVI VALENCIA","has_results":false},{"nct_id":"NCT03534453","title":"Olaparib Tablets Maintenance Monotherapy Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":229,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT07282288","title":"A RCT Study on Autologous Cell Injection Into the Ovaries of Patients With POR","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":198,"lead_sponsor_name":"Peking University Third Hospital","has_results":false},{"nct_id":"NCT05703308","title":"Menstrual Blood Stem Cells in Poor Ovarian Responders","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":180,"lead_sponsor_name":"Avicenna Research Institute","has_results":false},{"nct_id":"NCT05321511","title":"Comparison of Triggers in Double Ovarian Stimulation (DuoStim).","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":165,"lead_sponsor_name":"Instituto Bernabeu","has_results":false},{"nct_id":"NCT04168892","title":"Anti-Müllerian Hormone (AMH) Measured With Fully Automated Assay Versus AFC in the Prediction of Ovarian Response","phase":"","overall_status":"COMPLETED","enrollment_count":160,"lead_sponsor_name":"Andros Day Surgery Clinic","has_results":false},{"nct_id":"NCT07282314","title":"A RCT Study on Autologous PRP Injection in Patients With POR","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":142,"lead_sponsor_name":"Peking University Third Hospital","has_results":false},{"nct_id":"NCT03830697","title":"A Trial Study on Acupuncture Treatment of Poor Ovarian Response","phase":"NA","overall_status":"UNKNOWN","enrollment_count":140,"lead_sponsor_name":"Shaanxi Hospital of Traditional Chinese Medicine","has_results":false},{"nct_id":"NCT04310293","title":"Novel Therapy for Poor Responders Management","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Al Baraka Fertility Hospital","has_results":false},{"nct_id":"NCT03994614","title":"the Effect of Transcutaneous Electrical Acupoint Stimulation on the Quality of Oocyte on Poor Ovarian Response(POR)","phase":"NA","overall_status":"COMPLETED","enrollment_count":92,"lead_sponsor_name":"ShangHai Ji Ai Genetics & IVF Institute","has_results":false},{"nct_id":"NCT06617988","title":"SIRT3 Expression in Granulosa Cells and the Levels of Follicular Fluid Metabolites Among POR Subgroups","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":80,"lead_sponsor_name":"Shandong University of Traditional Chinese Medicine","has_results":false},{"nct_id":"NCT06089395","title":"The Effect of Jiajian Guishen Granules on the Modulation of Ovarian Function in Patients With Poor Ovarian Response(POR)","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":76,"lead_sponsor_name":"Shi Yun","has_results":false},{"nct_id":"NCT03433768","title":"Androgen Receptor mRNA Expression is Positively Associated With Live Birth in Women Undergoing IVF Independently of the Type of Ovarian Response","phase":"","overall_status":"COMPLETED","enrollment_count":67,"lead_sponsor_name":"Aristotle University Of Thessaloniki","has_results":false},{"nct_id":"NCT04013984","title":"Acupuncture for Treatment of Patients With Poor Ovarian Response","phase":"NA","overall_status":"COMPLETED","enrollment_count":43,"lead_sponsor_name":"Royan Institute","has_results":false},{"nct_id":"NCT07270081","title":"Follicular Flushing Using Double Lumen Needle Versus Direct Aspiration in Low Prognosis Patients According to the POSEIDON Criteria","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Instituto Bernabeu","has_results":false},{"nct_id":"NCT04024722","title":"Improving in Vitro Fertilization in Women With Poor Ovarian Response","phase":"NA","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Barzilai Medical Center","has_results":false},{"nct_id":"NCT03447184","title":"Long-term Endogenous Androgen Priming in Bologna Criteria Poor Responder Patients - A Pilot Study","phase":"","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Mỹ Đức Hospital","has_results":false},{"nct_id":"NCT07085312","title":"Exosome-Enriched Culture Media to Enhance In Vitro Maturation and Embryo Development in Poor Ovarian Responders Undergoing IVF","phase":"NA","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Fertiaguerrevere","has_results":false}],"total":23},"guidelines":[],"source":"Drug Landscape verified database"}